Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) is likely to benefit from orders for new processors to be used in Samsung Electronics Co’s next generation of Galaxy smartphones, JPMorgan Securities said on Monday.
Similar to its previous Galaxy S3, Samsung is expected to adopt multiple solutions for the application processors and baseband chips in its new Galaxy S4, which will be unveiled in New York on March 14, JPMorgan said in a note to clients.
For the US version of the S4, Samsung will probably use Qualcomm Inc’s Snapdragon 600 quad-core processor, which is manufactured using TSMC’s 28-nanometer (nm) process technology, the brokerage said.
However, the South Korean electronics giant may use its in-house eight-core processor for the S4 models in Europe, JPMorgan said.
STRONG OUTLOOK
“We see Samsung’s switch to Qualcomm for its US shipments as positive for the semiconductor sector,” Rick Hsu (徐稦成), a Taipei-based analyst at JPMorgan, wrote in the note.
“We believe TSMC is enjoying the extra benefits — a reason why its first-quarter revenue is expected to be stronger than seasonally expected,” he said.
At an investor meeting last month, TSMC forecast its first-quarter sales would be between NT$127 billion (US$4.28 billion) and NT$129 billion, changing little from the previous quarter despite coming during the high-tech sector’s slow season.
TSMC chairman Morris Chang (張忠謀) said the 28nm process will serve as the driving force behind the company’s sales growth for this year, with production of 28nm process chips set to triple from a year earlier.
ONLY TWO
Hsu said that TSMC, along with Samsung, are two of the few foundries capable of operating the 28nm process commercially, meaning that extra demand from Qualcomm could take away capacity for other customers.
As a result, he believes TSMC’s revenue growth in the second quarter would likely increase by less than 10 percent, which will be lower than the seasonal level, since the extra 28nm orders from Qualcomm will already be reflected in first quarter sales.
ADDED BENEFITS
Hsu also said he expected the extra 28nm orders would benefit integrated circuit packaging and testing service providers — including Taiwan’s Advanced Semiconductor Engineering Inc (ASE. 日月光半導體) and Siliconware Precision Industries Co (SPIL, 矽品精密) — beginning in the second quarter.
TSMC shares were down 0.48 percent to NT$104.5 as of 12:09pm in Taipei trading yesterday.
ASE shares had dropped 0.61 percent to NT$24.5 and SPIL shares were down 0.32 percent to NT$31.35.
JPMorgan Chase & Co chief executive officer Jamie Dimon on Tuesday quipped that his company is likely to outlast the Chinese Communist Party (CCP), while reiterating the bank’s commitment to the country in wide-ranging comments that also touched on Taiwan, free speech and former US president Donald Trump. “We hope to be there [in China] for a long time,” Dimon told a panel discussion at the Boston College Chief Executives Club. Relaying a “joke” he made during a recent visit to Hong Kong, he said “The communist party is celebrating its 100th year. So is JPMorgan. And I’ll make you a
The Kaohsiung City Government yesterday said it would impose a property hoarding tax as it is seeking to contain speculation in the real-estate market, calling recent price increases “abnormal.” The announcement came in support of the Ministry of Finance’s call for local governments to levy a high tax rate on people with more than one property. Ministry officials on Tuesday discussed strategies to rein in speculation with the nation’s six special municipalities, as well as the Hsinchu city and county governments. About 84,000 out of 1.06 million housing units in Kaohsiung are not residential property, the city government said in a
PharmaEssentia Corp (藥華醫藥) shares have jumped 80.56 percent since the company obtained a US polycythemia vera (PV) drug license for its new interferon drug Besremi (ropeginterferon alfa-2b-njft) on Nov. 12. Shares on Friday closed at NT$195 in Taipei trading, up from the stock’s closing price of NT$108 on Nov. 12. PV is a rare, chronic and life-threatening blood cancer linked to a stem cell mutation in the bone marrow that results in an overproduction of blood cells and places sufferers at risk of having a blood clot, stroke or heart attack. PharmaEssentia is preparing to make Besremi available in the US in the
BOOST EXPECTED: Higher market prices would offset effects of the industry’s transition to more climate-friendly production methods, a company official said China Steel Corp (CSC, 中鋼) expects steel demand to increase on the back of governments around the world subsidizing infrastructure construction amid a stabilizing COVID-19 pandemic, CSC chairman Wong Chao-tung (翁朝棟) told an investors’ meeting yesterday. “After getting through the hard times, I foresee at least one year, very possibly two years, of strong steel market,” Wong said. Calling a dip in steel prices a “short respite for the market,” Wong said that it would likely bounce back early next year on the back of mild winter temperatures around the world allowing construction activity. Despite COVID-19 spikes in some regions and increased
RSS